Integral Diagnostics Ltd. (AU:IDX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Morgan Stanley has become a substantial shareholder in Integral Diagnostics Ltd, acquiring a 5.67% voting power through various entities, including securities lending agreements. This move positions Morgan Stanley as a significant player in the Australian healthcare services sector, potentially influencing the company’s strategic decisions and market performance.
For further insights into AU:IDX stock, check out TipRanks’ Stock Analysis page.